Loading insider details...
Latest Form 4 (Jul 23, 2026): Grant/Award of 8,251 VRTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 23, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 8,251 | n/a |
| Feb 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,518 | $736.4K |
| Feb 23, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Exercise/Conversion | 23,479 | $3.65M |
| Feb 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 5,789 | n/a |
| Feb 18, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 3,548 | $1.73M |
| Feb 12, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 2,057 | $963.5K |
| Jan 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 7,866 | n/a |
| Feb 28, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 3,703 | $1.78M |
| Feb 26, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 2,470 | $1.19M |
| Feb 19, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 2,139 | $991.3K |